نتایج جستجو برای: 2 inhibitors
تعداد نتایج: 2655500 فیلتر نتایج به سال:
The issue of the risk-benefit assessment of cyclooxygenase-2 (COX-2) inhibitors, as compared to traditional non-steroidal anti-inflammatory drugs (tNSAIDs), is far from being resolved. These compounds need to be carefully re-evaluated in order to avoid hasty conclusions, as it happened when COX-2 inhibitors were introduced into clinical practice. Several arguments support the concept, that COX-...
BACKGROUND/AIM Celecoxib, a cyclooxygenase-2 inhibitor and antiangiogenic agent, has demonstrated potent anticancer effects in preclinical studies and in human clinical trials. To evaluate the potential utility of this agent in the treatment of retinoblastoma, the authors investigated the effects of celecoxib in retinoblastoma cell lines and in a murine model of this disease. METHODS Growth i...
Abstract Background and Aims The number of people suffering from diabetes has exceeded 400 million worldwide. incidence anemia in type 2 mellitus (T2D) patients is about twice that non-diabetic patients. Moreover, with T2D who have chronic kidney disease are at higher risk developing it also occurs earlier. Therefore worth investigating the problem This study was conducted to compare effects ne...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید